Literature DB >> 19204264

Early MRI in optic neuritis: the risk for disability.

J K Swanton1, K T Fernando, C M Dalton, K A Miszkiel, D R Altmann, G T Plant, A J Thompson, D H Miller.   

Abstract

BACKGROUND: MRI findings influence the risk of patients with optic neuritis (ON) developing clinically definite (CD) multiple sclerosis (MS) but their influence on future disability is less clear.
OBJECTIVE: To investigate in patients with ON the influence of lesion number, location and activity, and non-lesion MRI measures obtained on early scans on disability.
METHODS: A total of 106 of 143 prospectively recruited patients with ON had reached a scheduled 5-year follow-up, of whom 100 were evaluated clinically. Lesion number, location, and activity measures were analyzed at baseline (within 3 months of onset) and lesion activity measures were studied at 3-month follow-up. Brain atrophy, magnetization transfer ratio, and spectroscopy measures were also analyzed. Ordinal logistic regression assessed the association between early MRI findings and subsequent disability.
RESULTS: At median 6 years follow-up, 48% had converted to CDMS and 52% remained with clinically isolated syndrome (median Expanded Disability Status Scale 2 and 1). In the final models, both the presence and the number of spinal cord lesions at baseline (odds ratios [OR] 3.30, 1.94) and new T2 lesions at follow-up (OR 7.12, 2.06) were significant independent predictors of higher disability. Disability was also predicted by the presence at baseline of gadolinium-enhancing lesions (OR 2.78) and number of infratentorial lesions (OR 1.82). Only spinal cord lesions predicted disability in patients converting to CDMS.
CONCLUSION: Spinal cord, infratentorial, and gadolinium lesions within 3 months of optic neuritis onset and new T2 lesions after 3 months predicted disability after 6 years; only spinal cord lesions were predictive of disability in those developing clinically definite multiple sclerosis.

Entities:  

Mesh:

Year:  2009        PMID: 19204264     DOI: 10.1212/01.wnl.0000341935.41852.82

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

Review 1.  Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients.

Authors:  Mike P Wattjes; Àlex Rovira; David Miller; Tarek A Yousry; Maria P Sormani; Maria P de Stefano; Mar Tintoré; Cristina Auger; Carmen Tur; Massimo Filippi; Maria A Rocca; Franz Fazekas; Ludwig Kappos; Chris Polman
Journal:  Nat Rev Neurol       Date:  2015-09-15       Impact factor: 42.937

2.  Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010.

Authors:  Stuart D Cook; Suhayl Dhib-Jalbut; Peter Dowling; Luca Durelli; Corey Ford; Gavin Giovannoni; June Halper; Colleen Harris; Joseph Herbert; David Li; John A Lincoln; Robert Lisak; Fred D Lublin; Claudia F Lucchinetti; Wayne Moore; Robert T Naismith; Carlos Oehninger; Jack Simon; Maria Pia Sormani
Journal:  Int J MS Care       Date:  2012

Review 3.  Spinal cord MRI in multiple sclerosis--diagnostic, prognostic and clinical value.

Authors:  Hugh Kearney; David H Miller; Olga Ciccarelli
Journal:  Nat Rev Neurol       Date:  2015-05-26       Impact factor: 42.937

4.  Criteria improving multiple sclerosis diagnosis at the first MRI.

Authors:  Nathalie Caucheteux; Adil Maarouf; Margaux Genevray; Emmanuelle Leray; Romain Deschamps; Marie P Chaunu; Laure Daelman; Jean C Ferré; Olivier Gout; Jean Pelletier; Laurent Pierot; Gilles Edan; Ayman Tourbah
Journal:  J Neurol       Date:  2015-02-17       Impact factor: 4.849

Review 5.  MRI and multiple sclerosis-the evolving role of MRI in the diagnosis and management of MS: a clinician's perspective.

Authors:  H Kearney; A M Cahalane; R P Killeen; C McGuigan
Journal:  Ir J Med Sci       Date:  2017-10-10       Impact factor: 1.568

6.  Multiple sclerosis: Lesion location may predict disability in multiple sclerosis.

Authors:  Jaume Sastre-Garriga; Mar Tintoré
Journal:  Nat Rev Neurol       Date:  2010-12       Impact factor: 42.937

Review 7.  Imaging Markers for Monitoring Disease Activity in Multiple Sclerosis.

Authors:  Suradech Suthiphosuwan; David Kim; Aditya Bharatha; Jiwon Oh
Journal:  Curr Treat Options Neurol       Date:  2017-05       Impact factor: 3.598

8.  Celastrol Attenuates Multiple Sclerosis and Optic Neuritis in an Experimental Autoimmune Encephalomyelitis Model.

Authors:  Hongbin Yang; Chang Liu; Jie Jiang; Yuena Wang; Xiaoyu Zhang
Journal:  Front Pharmacol       Date:  2017-02-10       Impact factor: 5.810

Review 9.  Optic neuritis as an early sign of multiple sclerosis.

Authors:  Nilufer Kale
Journal:  Eye Brain       Date:  2016-10-26

10.  Asymptomatic spinal cord lesions do not predict the time to disability in patients with early multiple sclerosis.

Authors:  Iris Dekker; Madeleine H Sombekke; Birgit I Witte; Jeroen Jg Geurts; Frederik Barkhof; Bernard Mj Uitdehaag; Joep Killestein; Mike P Wattjes
Journal:  Mult Scler       Date:  2017-11-06       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.